Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Somnath G. Kandekar, Mayank Singhal, Kiran B. Sonaje & Yogeshvar N. Kalia. (2019) Polymeric micelle nanocarriers for targeted epidermal delivery of the hedgehog pathway inhibitor vismodegib: formulation development and cutaneous biodistribution in human skin. Expert Opinion on Drug Delivery 16:6, pages 667-674.
Read now
Read now
Teresa Amaral & Claus Garbe. (2017) Non-melanoma skin cancer: new and future synthetic drug treatments. Expert Opinion on Pharmacotherapy 18:7, pages 689-699.
Read now
Read now
Articles from other publishers (15)
Chu Zhou, Haonan Zhang, Peiru Wang, Lei Shi, Long Wen, Qi Chen, Guolong Zhang, Cheng Wang & Xiuli Wang. (2021)
Optical coherence tomography‐based non‐invasive evaluation of premalignant lesions in
SKH
‐1 mice
. Journal of Biophotonics 14:6.
Crossref
Crossref
Gabriella Brancaccio, Elvira Moscarella, Giulia Briatico, Pasquale Verolino, Roberto Alfano & Giuseppe Argenziano. (2020) Challenges and new perspectives in the treatment of advanced cutaneous squamous cell carcinoma. Minerva Medica 111:6.
Crossref
Crossref
Idowu Jonas Sagbo & Wilfred Otang-Mbeng. (2020) Anti-Proliferative and Genotoxic Activities of the Helichrysum petiolare Hilliard & B.L. Burtt. Scientia Pharmaceutica 88:4, pages 49.
Crossref
Crossref
Franchesca D. Choi, Christina N. Kraus, Ashley N. Elsensohn, Sama K. Carley, Larisa M. Lehmer, Rebecca T. Nguyen, Kenneth G. Linden & Jessica Shiu. (2020) Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review. Journal of the American Academy of Dermatology 82:2, pages 440-459.
Crossref
Crossref
Vijaybabu KPunnagai K2. (2019) In-vitro Anti-proliferative Effects of Ethanolic Extract of Vanilla Planifolia Leaf Extract against A431 Human Epidermoid Carcinoma Cells. Biomedical & Pharmacology Journal 12:3, pages 1141-1146.
Crossref
Crossref
Efthymia Soura, Eleni Gagari & Alexander Stratigos. (2019) Advanced cutaneous squamous cell carcinoma: how is it defined and what new therapeutic approaches are available?. Current Opinion in Oncology 31:5, pages 461-468.
Crossref
Crossref
E. Degache, J. Crochet, N. Simon, M. Tardieu, S. Trabelsi, M. Moncourier, I. Templier, L. Foroni, A. Lemoigne, N. Pinel, H. Gil, L. Bouillet, M. T. Leccia & J. Charles. (2018) Major response to pembrolizumab in two patients with locally advanced cutaneous squamous cell carcinoma. Journal of the European Academy of Dermatology and Venereology 32:7, pages e257-e258.
Crossref
Crossref
Efthymia Soura, Michaela Plaka, Vasiliki Chasapi, Christina Antoniou & Alexander Stratigos. (2018) Vismodegib persistence and discontinuation patterns in Greek patients from a real world setting. Dermatologic Therapy 31:1, pages e12553.
Crossref
Crossref
Blair Barton & Brian Moore. 2018. Temporal Bone Cancer. Temporal Bone Cancer
67
81
.
Faezeh Khodaie, Yalda Khazaei-Poul & Taraneh Moini-Zanjani. (2017) Anti-Proliferative Effects of Piroxicam and Nimesulide on A431 Human Squamous Carcinoma Cell Line. International Journal of Cancer Management 10:4.
Crossref
Crossref
Caroline Z. Tan, Kerri E. Rieger & Kavita Y. Sarin. (2017) Basosquamous Carcinoma: Controversy, Advances, and Future Directions. Dermatologic Surgery 43:1, pages 23-31.
Crossref
Crossref
E. Soura, V. Chasapi & A.J. Stratigos. (2016) Programmed cell death protein-1 inhibitors for immunotherapy of advanced nonmelanoma skin cancer: showing early promise. British Journal of Dermatology 175:6, pages 1150-1151.
Crossref
Crossref
T. Gracia-Cazaña, N. Salazar, A. Zamarrón, M. Mascaraque, S.R. Lucena & Á. Juarranz. (2016) Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part II: Photodynamic Therapy, Vismodegib, Cetuximab, Intralesional Methotrexate, and Radiotherapy. Actas Dermo-Sifiliográficas (English Edition) 107:9, pages 740-750.
Crossref
Crossref
T. Gracia-Cazaña, N. Salazar, A. Zamarrón, M. Mascaraque, S.R. Lucena & Á. Juarranz. (2016) Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte II: terapia fotodinámica, vismodegib, cetuximab, metotrexato intralesional y radioterapia. Actas Dermo-Sifiliográficas 107:9, pages 740-750.
Crossref
Crossref
E. Soura, M. Plaka, C. Dessinioti, K. Syrigos & A.J. Stratigos. (2016) Can hair re-growth be considered an early clinical marker of treatment resistance to Hedgehog inhibitors in patients with advanced basal cell carcinoma? A report of two cases. Journal of the European Academy of Dermatology and Venereology 30:10, pages 1726-1729.
Crossref
Crossref